Skip to content

Ketone Esters and Metabolism During Recovery from Endurance Exercise

Effect of Ketone Esters Ingested During Recovery on Metabolism and Subsequent Exercise Capacity

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06846840
Enrollment
18
Registered
2025-02-26
Start date
2024-11-01
Completion date
2025-05-01
Last updated
2025-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Metabolism

Brief summary

Infusion of beta-hydroxybutyrate can suppress endogenous glucose production, which may result in increased net liver glycogen storage. If ketone esters exert similar effects, then the increase in liver glycogen storage may have implication for recovery from exercise and subsequent exercise performance. The aim of this study is to assess the effects of ketone esters ingested during recovery from exercise, on metabolism and subsequent exercise capacity.

Interventions

DIETARY_SUPPLEMENTKetone ester

0.29 g per kilogram body mass per hour of ketone monoester (R)-3-hydroxybutyrate (R)-3-hydroxybutyl

DIETARY_SUPPLEMENTPlacebo

Medium chain triglycerides and bitter tastant (Bitrex)

Sponsors

University of Bath
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* VO2max ≥ 45mL.kg-1.min-1 * Weekly aerobic training \> 3hours. * 2years running experience. * BMI \< 30kg/m2

Exclusion criteria

* \<18yrs or \>60yrs of age * Habitual smoker within last 5 years. * History of uncontrollable metabolic or respiratory disease. * Currently taking medication, following a low carbohydrate or ketogenic diet, or consuming nutritional ketone supplements. * History of Irritable Bowel Syndrome

Design outcomes

Primary

MeasureTime frameDescription
Glucose concentrations240 minutesBlood glucose concentrations during the recovery period (240 minutes)

Secondary

MeasureTime frameDescription
Non-oxidative fate of ingested sucrose240 minutesNon-oxidative fate of ingested glucose measured by appearance of 13C on breath CO2 from high 13C sucrose ingested during recovery
Exercise capacity240 minutesTime to exhaustion running at 70% of maximal aerobic capacity after the recovery period

Other

MeasureTime frameDescription
Plasma insulin concentrations240 minutesPlasma insulin concentrations during 240 minutes of recovery
Blood beta-hydroxybutyrate concentrations240 minutesBlood beta-hydroxybutyrate concentrations throughout the 240 minute recovery
Blood bicarbonate240 minutesBlood bicarbonate concentrations during 240 minutes of recovery
Blood pH240 minutesBlood pH during 240 minutes of recovery
Urinary urea240 minutesUrea in urine, determined by urea concentration multiplied by total urine output during the 240 minutes of recovery
Blood lactate concentrations240 minutesBlood lactate concentrations during 240 minutes of recovery

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026